Institutional Ownership
Heron Therapeutics Inc
CUSIP 427746102COMHRTXQ1 2026
13D / 13G Filings
59
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
19.0%
Max % of class reported
Institutional Holders
163
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
59 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Clearline Capital LP | 13G/A | 11.0% | 12.24M | SEC |
| 2 | Jan 30, 2026 | The Vanguard Group | 13G | 5.3% | 9.82M | SEC |
| 3 | Nov 26, 2025 | Clearline Capital LP | 13G | 11.0% | 9.71M | SEC |
| 4 | Oct 30, 2025 | The Vanguard Group | 13G/A | 4.6% | 8.46M | SEC |
| 5 | Oct 17, 2025 | Rubric Capital Management LP | 13D/A | 15.9% | — | SEC |
| 6 | Aug 12, 2025 | Rubric Capital Management LP | 13D/A | 17.5% | — | SEC |
| 7 | Nov 12, 2024 | Adage Capital Management, L.P. | 13G | 5.8% | 8.85M | SEC |
| 8 | Nov 8, 2024 | Blackrock, Inc. | 13G | 5.6% | 8.53M | SEC |
| 9 | Oct 24, 2024 | Blackrock, Inc. | 13G | 5.6% | 8.53M | SEC |
| 10 | May 31, 2024 | Rubric Capital Management LP | 13D/A | 17.7% | 26.71M | SEC |
49 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Heron Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rubric Capital Management LP | 30.05M | $24.04M |
| 2 | Clearline Capital LP | 12.24M | $9.79M |
| 3 | Blackrock, Inc. | 10.11M | $8.09M |
| 4 | Orbimed Advisors LLC | 9.82M | $7.85M |
| 5 | Velan Capital Investment Management LP | 8.75M | $7.00M |
| 6 | Millennium Management LLC | 7.63M | $6.11M |
| 7 | Tejara Capital Ltd | 6.34M | $5.07M |
| 8 | Tang Capital Management LLC | 6.25M | $5.00M |
| 9 | Palisade Capital Management, LP | 6.14M | $4.91M |
| 10 | Congress Park Capital LLC | 4.03M | $3.23M |